缬沙坦联合叶酸对老年高血压肾病患者降压及降同型半胱氨酸的临床研究(4)
 |
| 第1页 |
参见附件。
[9] Mochizuki S, Dahlf B, Shimizu M, et al.Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet, 2007, 369: 1431-1439.
[10] 全国高同型半胱氨酸血症与疾病学术研討会纪要.中华医学杂志，1999,79:406-409.
[11] Clarke R.Commentary：an updated review of the published studies of homocysteine and cardiovascular disease.Int J Epidemiol，2002：31(1)：70-71.
[12] Ozkan Y, Ozkan E, Simsek B. Plasma total homocysteine and cysteine levels as cardiovascular risk factor in coronary heart disease. Int J Cardiol,2002,82(4)：267-277.
[13] Ueland PM， Refsum H， Stabler SP， et al. Total homocysteine in plasma or serum： methods and clinical applications. Clin Chem，1993,39(9)：1764-1779.
[14] Selhub J， Jacques PF， Wilson PW， et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA，1993,270(22)：2693-2698.
[15] Semub J, Jaulues PF, Bostom AG, et al. Relationship between plasma homocysteine,vitamin status and extracranial carotid-artery stenoses in the Framingham study population. J Nutr,1996,126：1258-1265.
[16] 严江涛，汪道文.同型半胱氨酸与血管内皮功能失调的关系及其分子机制的研究进展.临床心血管病杂志，2004，20(4)：254-255 ......
您现在查看是摘要介绍页，详见PDF附件(5210kb)。